The field of the invention generally relates to systems and delivery devices for implanting vaso-occlusive devices for establishing an embolus or vascular occlusion in a vessel of a human or veterinary patient.
Vaso-occlusive devices or implants are used for a wide variety of reasons, including treatment of intra-vascular aneurysms. Commonly used vaso-occlusive devices include soft, helically wound coils formed by winding a platinum (or platinum alloy) wire strand about a “primary” mandrel. The relative stiffness of the coil will depend, among other things, on its composition, the diameter of the wire strand, the diameter of the primary mandrel, and the pitch of the resulting primary windings. The coil is then wrapped around a larger, “secondary” mandrel, and heat treated to impart a secondary shape. For example, U.S. Pat. No. 4,994,069, issued to Ritchart et al., describes a vaso-occlusive coil that assumes a linear, helical primary shape when stretched for placement through the lumen of a delivery catheter, and a folded, convoluted secondary shape when released from the delivery catheter and deposited in the vasculature.
In order to deliver the vaso-occlusive coils to a desired site in the vasculature, e.g., within an aneurismal sac, it is well-known to first position a small profile, delivery catheter or “micro-catheter” at the site using a steerable guidewire. Typically, the distal end of the micro-catheter is provided, either by the attending physician or by the manufacturer, with a selected pre-shaped bend, e.g., 45°, 90°, “J”, “S”, or other bending shape, depending on the particular anatomy of the patient, so that it will stay in a desired position for releasing one or more vaso-occlusive coil(s) into the aneurysm once the guidewire is withdrawn. A delivery or “pusher” wire is then passed through the micro-catheter, until a vaso-occlusive coil coupled to a distal end of the delivery wire is extended out of the distal end opening of the micro-catheter and into the aneurysm. The vaso-occlusive device is then released or “detached” from the end delivery wire, and the delivery wire is withdrawn back through the catheter. Depending on the particular needs of the patient, one or more additional occlusive devices may be pushed through the catheter and released at the same site.
One well-known way to release a vaso-occlusive coil from the end of the pusher wire is through the use of an electrolytically severable junction, which is a small exposed section or detachment zone located along a distal end portion of the pusher wire. The detachment zone is typically made of stainless steel and is located just proximal of the vaso-occlusive device. An electrolytically severable junction is susceptible to electrolysis and disintegrates when the pusher wire is electrically charged in the presence of an ionic solution, such as blood or other bodily fluids. Thus, once the detachment zone exits out of the catheter distal end and is exposed in the vessel blood pool of the patient, a current applied through an electrical contact to the conductive pusher wire completes a circuit with a return electrode, and the detachment zone disintegrates due to electrolysis.
In “monopolar” systems, return electrodes include electrodes attached to the patient's skin and conductive needles inserted through the skin at a remote site. In “bipolar” systems, return electrodes are located on the pusher wire but electrically insulated from the conductive path ending in the detachment zone.
The anode is made up of an insulated core wire, which runs through the pusher wire, is attached to the electrical contact at the proximal end, and forms the detachment zone at the distal end. The anode electrical contact is a metallic tube secured to the proximal end of the pusher wire.
Perceived problems with current vaso-occlusive coil delivery systems include lack of stability at the junction where the metallic tube is secured to the proximal end of the pusher wire. Both orthogonal and axial forces may be exerted on the junction when the pusher wire is positioned in the micro-catheter and when the anode electrical contract is connected to and disconnected from the power supply. These forces may lead to kinking and buckling of the pusher wire. These forces may also damage the junction and may adversely impact detachment of the embolic coil by electrolysis.
In one embodiment, a delivery wire assembly for delivery of an occlusive device to a location in a patient's vasculature includes a delivery wire conduit having a proximal tubular portion coupled to a distal coil portion, the respective tubular and coil portions defining a conduit lumen, wherein the proximal tubular portion tapers down in cross section at a proximal end thereof, and a core wire disposed in the conduit lumen and having a distal end coupled to an occlusive device. The delivery wire assembly also includes an electrical contact coupled to a proximal end of the core wire, wherein the electrical contact includes a connection collar. The connection may be a metal tube or a metal coil. The electrical contact and the core wire form an anode of an electrolytic detachment circuit for detaching the occlusive device from the core wire. Further, the delivery wire assembly includes a ground contact, where the electrical contact and the core wire form a first conductive path, and the ground contact and the delivery wire conduit form a second conductive path. The delivery wire assembly also includes a sleeve disposed around at least a portion of the delivery wire conduit. The sleeve is secured to the delivery wire conduit by heat lamination.
In another embodiment, an occlusive coil delivery system includes a delivery catheter, a delivery wire assembly, and a power supply. The delivery catheter includes a proximal end, a distal end, and a catheter lumen extending between the proximal and distal ends. The delivery wire assembly includes a delivery wire conduit having a proximal tubular portion coupled to a distal coil portion, the respective tubular and coil portions defining a conduit lumen, where the proximal tubular portion tapers down in cross section at a proximal end thereof, and a core wire disposed in the conduit lumen and having a distal end coupled to an occlusive coil. The delivery wire assembly also includes an electrical contact coupled to a proximal end of the core wire, the electrical contact and core wire forming an anode of an electrolytic detachment circuit for detaching the occlusive coil from the core wire. The electrical contact includes a connection collar. The power supply is electrically connected to the core wire. Further, the delivery wire assembly includes a ground contact, where the electrical contact and the core wire form a first conductive path, the ground contact and the delivery wire conduit form a second conductive path, and the power supply is electrically connected to the respective first and second conductive paths.
In yet another embodiment, a delivery wire assembly for delivery of an occlusive device to a location in a patient's vasculature includes a delivery wire conduit having a proximal tubular portion coupled to a distal coil portion, the respective tubular and coil portions defining a conduit lumen and a core wire disposed in the conduit lumen and having a distal end coupled to an occlusive device. The delivery wire assembly also includes an elongate electrical contact body at least partially seated in the conduit lumen and coupled to a proximal end of the core wire, the electrical contact body and the proximal tubular portion forming a junction and a coil collar disposed around the electrical contact body near the junction. The electrical contact body may be a tube, a tubular body mode of coils, or a mandrel. The electrical contact body is coupled to the proximal tubular portion with a soldering bond. The coil collar is coupled to the electrical contact body and the proximal tubular portion with an adhesive or a soldering bond. The electrical contact body is coupled to the core wire with a soldering bond or a welding bond. The coil collar has an open pitch in the range of 10% to 15%. Further, the delivery wire assembly includes a ground contact, where the electrical contact body and the core wire form a conductive path, and the ground contact and the delivery wire conduit form a second conductive path.
In still another embodiment, a delivery wire assembly includes a delivery wire conduit having a proximal tubular portion coupled to a distal coil portion, the respective tubular and coil portions defining a conduit lumen, a core wire disposed in the conduit lumen and having a distal end coupled to an occlusive coil, an elongate electrical contact body at least partially seated in the conduit lumen and coupled to a proximal end of the core wire, and the electrical contact body and the proximal tubular portion forming a junction. The delivery wire conduit also includes a proximal end, where the inner surface of the proximal end flares out in a proximal direction.
Referring now to the drawings in which like reference numbers represent corresponding parts throughout, and in which:
The delivery catheter 100 may include a braided-shaft construction of stainless steel flat wire that is encapsulated or surrounded by a polymer coating. By way of non-limiting example, HYDROLENE® is a polymer coating that may be used to cover the exterior portion of the delivery catheter 100. Of course, the system 10 is not limited to a particular construction or type of delivery catheter 100 and other constructions known to those skilled in the art may be used for the delivery catheter 100.
The inner lumen 106 is advantageously coated with a lubricious coating such as PTFE to reduce frictional forces between the delivery catheter 100 and the respective delivery wire assembly 200 and occlusive coil 300 being moved axially within the lumen 106. The delivery catheter 100 may include one or more optional marker bands 108 formed from a radiopaque material that can be used to identify the location of the delivery catheter 100 within the patient's vasculature system using imaging technology (e.g., fluoroscope imaging). The length of the delivery catheter 100 may vary depending on the particular application, but generally is around 150 cm in length. Of course, other lengths of the delivery catheter 100 may be used with the system 10 described herein.
The delivery catheter 100 may include a distal end 104 that is straight as illustrated in
Still referring to
The delivery wire assembly 200 further includes a core wire 210 that extends from the proximal end 202 of the delivery wire assembly 200 to a location that is distal with respect to the distal end 204 of the delivery wire assembly 200. The core wire 210 is disposed within a conduit lumen 212 that extends within an interior portion of the delivery wire conduit 213. The core wire 210 is formed from an electrically conductive material such as stainless steel wire. The proximal end 214 of the core wire 210 (shown in phantom) is electrically coupled to an electrical contact 216 located at the proximal end 202 of the delivery wire assembly 200. The electrical contact 216 is configured to interface with a corresponding electrical contact (not shown) in the power supply 400.
A portion of the core wire 210 is advantageously coated with an insulative coating 218. The insulative coating 218 may include polyimide. The entire length of the core wire 210 is coated with an insulative coating 218, except for the proximal end 214 of the core wire 210 that contacts the electrical contact 216, and a small region 220 located in a portion of the core wire 210 that extends distally with respect to the distal end 204 of the delivery wire assembly 200. This latter, “bare” portion of the core wire 210 forms the electrolytic detachment zone 220, which dissolves upon application of electrical current from the power supply 400.
Still referring to
The distal end 222 of the core wire 210 is connected to the proximal end 302 of the occlusive coil 300 at a junction 250. Various techniques and devices can be used to connect the core wire 210 to the occlusive coil 300, including laser melting, and laser tack, spot, and continuous welding. It is preferable to apply an adhesive 240 to cover the junction 250 formed between the distal end 222 of the core wire 210 and the proximal end 302 of the occlusion coil 300. The adhesive 240 may include an epoxy material which is cured or hardened through the application of heat or UV radiation. For example, the adhesive 240 may include a thermally cured, two-part epoxy such as EPO-TEK® 353ND-4 available from Epoxy Technology, Inc., 14 Fortune Drive, Billerica, Mass. The adhesive 240 encapsulates the junction 250 and increases its mechanical stability.
Still referring to
The power supply 400 preferably includes an onboard energy source, such as batteries (e.g., a pair of AAA batteries), along with drive circuitry 402. The drive circuitry 402 may include one or more microcontrollers or processors configured to output a driving current. The power supply 400 illustrated in
A visual indicator 406 (e.g., LED light) is used to indicate when the proximal end 202 of delivery wire assembly 200 has been properly inserted into the power supply 400. Another visual indicator 407 is activated if the onboard energy source needs to be recharged or replaced. The power supply 400 includes an activation trigger or button 408 that is depressed by the user to apply the electrical current to the sacrificial electrolytic detachment zone 220. Once the activation trigger 408 has been activated, the driver circuitry 402 automatically supplies current until detachment occurs. The drive circuitry 402 typically operates by applying a substantially constant current, e.g., around 1.5 mA.
The power supply 400 may include optional detection circuitry 410 that is configured to detect when the occlusive coil 300 has detached from the core wire 210. The detection circuitry 410 may identify detachment based upon a measured impedance value. A visual indicator 412 may indicate when the power supply 400 is being supplied to the current to the sacrificial electrolytic detachment zone 220. Another visual indicator 414 may indicate when the occlusive coil 300 has detached from the core wire 210. As an alternative to the visual indicator 414, an audible signal (e.g., beep) or even tactile signal (e.g., vibration or buzzer) may be triggered upon detachment. The detection circuitry 410 may be configured to disable the drive circuitry 402 upon sensing detachment of the occlusive coil 300.
The power supply 400 may also contain another visual indicator 416 that indicates to the operator when non-bipolar delivery wire assembly is inserted into the power supply 400. As explained in the background above, non-bipolar delivery wire assemblies use a separate return electrode that typically is in the form of a needle that was inserted into the groin area of the patient. The power supply 400 is configured to detect when a non-bipolar delivery wire assembly has been inserted. Under such situations, the visual indicator 416 (e.g., LED) is turned on and the user is advised to insert the separate return electrode (not shown in
Still referring to
A ground contact 246 for the second conductive path 244 may be disposed on a proximal end of the tubular portion 206 of the delivery wire conduit 213. In one embodiment, the ground contact 246 is simply an exposed portion of the tubular portion 206 since the tubular portion 206 is part of the second conductive path 244. For instance, a proximal portion of the tubular portion 206 that is adjacent to the electrical contact 216 may be covered with an insulation layer 254 such as polyimide as illustrated in
The ground contact 246 is configured to interface with a corresponding electrical contact (not shown) in the power supply 400 when the proximal end 202 of the delivery wire assembly 200 is inserted into the power supply 400. The ground contact 246 of the second conductive path 244 is, of course, electrically isolated with respect to the electrical contact 216 of the first conductive path 242.
As seen in
In
The embodiment depicted in
In another embodiment, shown in
The embodiment depicted in
In the embodiment shown in
As seen in
One or more marker coils 205 of the distal coil portion 208 may be formed from a radiopaque material (illustrated as solid marker coils 205 in distal coil portion 208). For example, the distal coil portion 208 may include a segment of stainless steel coil (e.g., 3 cm in length), followed by a segment of platinum coil (which is radiopaque and also 3 mm in length), followed by a segment of stainless steel coil (e.g., 37 cm in length), and so on and so forth.
An outer sleeve 263 or jacket surrounds a portion of the proximal tubular portion 206 and a portion of the distal coil portion 208 of the delivery wire conduit 213. The outer sleeve 263 covers the interface or joint formed between the proximal tubular portion 206 and the distal coil portion 208. The outer sleeve 263 may have a length of around 50 cm to around 54 cm. The outer sleeve 263 may be formed from a polyether block amide plastic material (e.g., PEBAX 7233 lamination). The outer sleeve 263 may include a lamination of PEBAX and HYDROLENE® that may be heat laminated to the delivery wire assembly 200. The OD of the outer sleeve 263 may be less than 0.02 inches and advantageously less than 0.015 inches.
The core wire 210, which runs through the delivery wire conduit 213, terminates at electrical contact 216 at one end and extends distally with respect to the distal coil portion 208 of the delivery wire conduit 213. The core wire 210 is coated with an insulative coating 218 such as polyimide except at the electrolytic detachment zone 220 and the proximal segment coupled to the electrical contact 216. The electrolytic detachment zone 220 is located several centimeters (e.g., about 0.02 mm to about 0.2 mm) distally with respect to the distal end of the distal coil portion 208. The core wire 210 may have an OD of around 0.00175 inches.
While various embodiments of the present invention have been shown and described, they are presented for purposes of illustration, and not limitation. Various modifications may be made to the illustrated and described embodiments without departing from the scope of the present invention, which is to be limited and defined only by the following claims and their equivalents.
The present application is a continuation-in-part of U.S. patent application Ser. No. 12/758,528, filed Apr. 12, 2010, which claims the benefit under 35 U.S.C. §119 to U.S. provisional patent application Ser. Nos. 61/170,043, filed Apr. 16, 2009 and 61/184,254, filed Jun. 4, 2009. The foregoing applications are hereby incorporated by reference into the present application in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
4994069 | Ritchart et al. | Feb 1991 | A |
5122136 | Guglielmi et al. | Jun 1992 | A |
5226911 | Chee et al. | Jul 1993 | A |
5304194 | Chee et al. | Apr 1994 | A |
5382259 | Phelps et al. | Jan 1995 | A |
5423829 | Pham et al. | Jun 1995 | A |
5522836 | Palermo | Jun 1996 | A |
5549624 | Mirigian et al. | Aug 1996 | A |
5578074 | Mirigian | Nov 1996 | A |
5582619 | Ken | Dec 1996 | A |
5685322 | Sung et al. | Nov 1997 | A |
5690666 | Berenstein et al. | Nov 1997 | A |
5743905 | Eder et al. | Apr 1998 | A |
5853418 | Ken et al. | Dec 1998 | A |
5919187 | Guglielmi et al. | Jul 1999 | A |
5984929 | Bashiri et al. | Nov 1999 | A |
6059779 | Mills | May 2000 | A |
6077260 | Wheelock et al. | Jun 2000 | A |
6102933 | Lee et al. | Aug 2000 | A |
6277125 | Barry et al. | Aug 2001 | B1 |
6280457 | Wallace et al. | Aug 2001 | B1 |
6409721 | Wheelock et al. | Jun 2002 | B1 |
6468266 | Bashiri et al. | Oct 2002 | B1 |
6537293 | Berryman et al. | Mar 2003 | B1 |
6575965 | Benett et al. | Jun 2003 | B1 |
6589230 | Gia et al. | Jul 2003 | B2 |
6953473 | Porter | Oct 2005 | B2 |
7198613 | Gandhi et al. | Apr 2007 | B2 |
7862602 | Licata et al. | Jan 2011 | B2 |
7921848 | Nikolchev et al. | Apr 2011 | B2 |
8398671 | Chen et al. | Mar 2013 | B2 |
20020091380 | Wheelock et al. | Jul 2002 | A1 |
20020151883 | Guglielmi | Oct 2002 | A1 |
20030120300 | Porter | Jun 2003 | A1 |
20030130689 | Wallace et al. | Jul 2003 | A1 |
20040002732 | Teoh et al. | Jan 2004 | A1 |
20040002733 | Teoh | Jan 2004 | A1 |
20040010243 | Klint | Jan 2004 | A1 |
20060135986 | Wallace et al. | Jun 2006 | A1 |
20060271097 | Ramzipoor et al. | Nov 2006 | A1 |
20060282112 | Griffin | Dec 2006 | A1 |
20070055302 | Henry et al. | Mar 2007 | A1 |
20070073334 | Ramzipoor | Mar 2007 | A1 |
20070123927 | Farnan | May 2007 | A1 |
20090018653 | Bashiri et al. | Jan 2009 | A1 |
20090024154 | Williams et al. | Jan 2009 | A1 |
20090062726 | Ford et al. | Mar 2009 | A1 |
20090062812 | Fitz et al. | Mar 2009 | A1 |
20090143786 | Bashiri et al. | Jun 2009 | A1 |
20090177261 | Teoh et al. | Jul 2009 | A1 |
20090299275 | Gandhi et al. | Dec 2009 | A1 |
20100076479 | Monstadt | Mar 2010 | A1 |
20100094395 | Kellett | Apr 2010 | A1 |
20110160835 | Licata et al. | Jun 2011 | A1 |
Number | Date | Country |
---|---|---|
10325130 | Sep 2004 | DE |
0826342 | Mar 1998 | EP |
9942038 | Aug 1999 | WO |
03053281 | Jul 2003 | WO |
2005070308 | Aug 2005 | WO |
2008064206 | May 2008 | WO |
2008085606 | Jul 2008 | WO |
2008144587 | Nov 2008 | WO |
WO 2008144587 | Nov 2008 | WO |
Entry |
---|
Non-Final Office Action mailed Jun. 12, 2012 for related U.S. Appl. No. 12/720,965, filed Mar. 10, 2010, 10 pages. |
Prosecution papers from related U.S. Appl. No. 12/122,636, filed May 15, 2008: Office Action Mailed Nov. 12, 2010; Response filed Mar. 14, 2011; Office Action mailed Jun. 7, 2011; Response filed Aug. 4, 2011; Final Office Action mailed Jan. 20, 2012; Response filed Feb. 28, 2012. |
Office Action mailed Jul. 15, 2011, in related European Application 08755795.5. |
Documents from related International Application No. PCT/US2008/064013, filed May 16, 2008: International Search Report mailed May 18, 2009; Written Opinion mailed May 18, 2009; Invitation to Pay Additional Fees mailed Jan. 29, 2009; International Preliminary Report on Patentability mailed Dec. 3, 2009. |
Documents from related International Application No. PCT/US2009/059797, filed Oct. 7, 2009: International Search Report mailed Nov. 30, 2009; Written Opinion mailed Nov. 30, 2009. |
Documents from related International Application No. PCT/US2010/026831, filed Mar. 10, 2010: International Search Report mailed Dec. 13, 2010; Written Opinion mailed Dec. 13, 2010. |
Documents from related International Application No. PCT/US2010/029700, filed Apr. 1, 2010: International Search Report mailed May 21, 2010; Written Opinion mailed May 21, 2010. |
PCT International Search Report and written Opinion for PCT/US2010/030753, Applicant Boston Scientific Scimed, Inc., Forms PCT/ISA/210, 220, and 237, dated Sep. 20, 2010 (19 pages). |
PCT Invitation to Pay Additional Fees for International Application No. PCT/US2010/030753, Applicant Boston Scientific Scimed, Inc., Form PCT/ISA/206 and Annex to Form PCT/ISA/206, Communication Relating to the Results of the Partial International Search (4 pages). |
Number | Date | Country | |
---|---|---|---|
20130184743 A1 | Jul 2013 | US |
Number | Date | Country | |
---|---|---|---|
61184254 | Jun 2009 | US | |
61170043 | Apr 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12758528 | Apr 2010 | US |
Child | 13791583 | US |